NOVOPEN 3 100IU|ml Injection 3ml

Frequently asked questions

• Onset of action

  The effect of this medicine can be observed within 30 to 60 minutes of administration of the dose.

• Duration of Effect

  The effect of this medicine lasts for an average duration of 6 to 8 hours.

• Safe with Alchohol?

  Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of both hypoglycemia (low blood glucose levels) and hyperglycemia (high blood glucose levels) depending on the quantity and frequency of alcohol consumption. This may cause severe side effects such as dizziness, drowsiness, increased thirst, increased hunger, mood changes, extreme fatigue, etc.

• Is it habit forming?

  No habit-forming tendencies were reported.

• Usage in pregnancy?

  This medicine is considered safe for use by pregnant women. However, it must be used only when necessary and the potential benefits outweigh the risks.

• Usage while breast-feeding?

  Use of insulin by breastfeeding women is considered acceptable. Breastfeeding women generally require lower doses of insulin.

• Allergy

  This medicine is not recommended for use in patients with a known allergy to insulin or any other inactive ingredients present along with it.

• Hypoglycemia

  This medicine is not recommended for use in patients suffering from decreased blood sugar levels (hypoglycemia) since it may worsen the patient's condition.

• Pregnancy

  This medicine is considered safe for use by pregnant women. However, it must be used only when necessary and the potential benefits outweigh the risks.

• Breast-feeding

  Use of insulin by breastfeeding women is considered acceptable. Breastfeeding women generally require lower doses of insulin.

• Hypersensitivity reactions

  This medicine may cause serious and occasionally fatal hypersensitivity reactions (severe allergic reactions) including anaphylactic shock in some patients. Seek immediate medical intervention if any signs and symptoms of an allergic reaction such as skin rash, sore throat, difficulty breathing, swelling of the face, etc. occur. If an anaphylactic reaction occurs, the treatment should be discontinued immediately and appropriate corrective measures should be undertaken.

• Hypoglycemia

  This medicine may cause hypoglycemia (low blood glucose levels) in some patients. This risk is especially higher in patients suffering from kidney diseases, malnourishment, pituitary gland diseases, etc. Close monitoring of blood glucose levels is recommended for such patients. Appropriate dose adjustments may be required based on the clinical condition. Your doctor may advise you to carry a sugar candy to counteract the effects of low blood sugar levels (hypoglycemia).

• Hypokalemia (Decreased potassium levels)

  This medicine should be used with caution in patients at risk of developing hypokalemia or patients suffering from hypokalemia since it may worsen the patient's condition. Close monitoring of potassium levels, appropriate corrective measures, or dose adjustments may be required based on the clinical condition of the patient.

Carefully follow all the instructions given by your doctor. Do not administer in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Do not stop the use of this medicine without consulting your doctor. Close monitoring of blood glucose levels and frequent follow-up visits with the doctor may be required based on the clinical condition. Never share an injection pen, cartridge, or syringe with another person, even if the needle has been changed.

• To be taken before food
• To be taken as instructed by doctor
• May cause sleepiness

• medlineplus.gov - Human Insulin [Internet]. Available from: https://medlineplus.gov/druginfo/meds/a682611.html [cited 9/7/2020]. 2020